• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Pregnancy and Postpartum Course
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Blogs » The Carlat Psychiatry Blog » When Doctors Get Addicted: Why the System Fails Them

The Carlat Psychiatry Blog
The Carlat Psychiatry Blog RSS FeedRSS

General Psychiatry

When Doctors Get Addicted: Why the System Fails Them

October 19, 2025
Daniel Carlat, MD
1759326490078.jpeg

It was a very bad day for Peter Grinspoon, MD. He arrived at his office prepared to see patients. Instead, he found DEA agents and state police rifling through his files.

They had the evidence: forged prescriptions, pill bottles, aliases.

Three felony charges followed.

At the time, Grinspoon was deep in opioid addiction—snorting crushed Vicodin between appointments, writing fake scripts for friends and family, and picking them up himself.

“I was fingerprinted in front of my patients,” he later wrote. “That was the end of my medical career—or so I thought.”

That raid began a long, difficult recovery. But in this month’s Carlat Hospital Psychiatry Report, Grinspoon tells a bigger story—one that challenges how we handle physician addiction. Because what came next wasn’t just treatment. It was punishment.

▸ A mandatory 90-day rehab he describes as outdated, religious, and alienating

▸ A state board that stripped his license and kept him under surveillance

▸ And a refusal to allow him evidence-based medications—like Suboxone—because of stigma His central argument is simple but urgent: Physicians with addictions are held to a different standard—one that often hurts more than it helps.

▸ Suboxone is often banned for doctors in recovery, despite lowering overdose deaths by up to 80%

▸ Abstinence-only expectations dominate, even when science says otherwise

▸ State boards prioritize liability over healing

▸ And the fear of losing one’s license keeps many from seeking help at all “A monitored physician is far safer than one too afraid to seek help.” Grinspoon believes it’s time to modernize the system:

▸ Treat addiction as a chronic illness—not a moral failure

▸ Offer pluralistic recovery options, including medications, not just abstinence

▸ Stop conflating impairment with treatment

▸ Make confidentiality the norm—not the exception

▸ And rebuild a culture where physicians are allowed to be human He’s lived both sides of the system: doctor in crisis, and now, a physician health leader. His story is a rare look behind the curtain—and a call for real reform.

This conversation appears in the Summer 2025 issue of The Carlat Hospital Psychiatry Report. Have you seen this double standard in your own system? Share if this calls for a change in how we treat physician addiction.

Follow me (Daniel Carlat, MD) for reflections on practical psychiatry and reform from the inside out.

Join the conversation on LinkedIn with Dr. Carlat. 

Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • MFB7e_Print_App_Access.png

    Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

    The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2683817953.jpg
    General Psychiatry

    The Rise of Long-Acting Buprenorphine

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.